Humana Inc. (NYSE:HUM) Given Average Recommendation of “Hold” by Analysts

Shares of Humana Inc. (NYSE:HUM) have earned an average rating of “Hold” from the twenty-six analysts that are currently covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and seven have given a buy rating to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $225.4783.

Several research analysts recently weighed in on HUM shares. Guggenheim decreased their price objective on shares of Humana from $312.00 to $252.00 and set a “buy” rating on the stock in a research report on Thursday, February 12th. Robert W. Baird dropped their target price on shares of Humana from $280.00 to $264.00 and set a “neutral” rating for the company in a research report on Thursday, December 11th. TD Cowen cut their price target on shares of Humana from $260.00 to $173.00 and set a “hold” rating for the company in a research note on Friday, February 13th. Raymond James Financial decreased their price target on shares of Humana from $340.00 to $230.00 and set an “outperform” rating on the stock in a report on Friday, February 13th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Humana from $274.00 to $180.00 and set a “neutral” rating on the stock in a research report on Friday, February 13th.

Insiders Place Their Bets

In other news, insider Sanjay K. Shetty purchased 810 shares of the company’s stock in a transaction on Monday, February 23rd. The stock was purchased at an average price of $185.21 per share, with a total value of $150,020.10. Following the completion of the purchase, the insider directly owned 11,657 shares in the company, valued at approximately $2,158,992.97. This trade represents a 7.47% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.37% of the stock is owned by insiders.

Hedge Funds Weigh In On Humana

Several institutional investors have recently modified their holdings of the company. Montag A & Associates Inc. lifted its position in Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after buying an additional 94 shares during the last quarter. CoreCap Advisors LLC grew its position in Humana by 54.4% during the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 37 shares during the last quarter. Fideuram Asset Management Ireland dac purchased a new position in shares of Humana during the fourth quarter worth approximately $27,000. Reflection Asset Management purchased a new position in shares of Humana during the fourth quarter worth approximately $29,000. Finally, Rosenberg Matthew Hamilton lifted its holdings in shares of Humana by 136.0% in the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after acquiring an additional 68 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.

Humana Price Performance

NYSE:HUM opened at $163.80 on Friday. Humana has a 52-week low of $163.60 and a 52-week high of $315.35. The stock has a fifty day moving average of $214.88 and a 200 day moving average of $249.14. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.00 and a current ratio of 2.00. The firm has a market capitalization of $19.66 billion, a price-to-earnings ratio of 16.68, a P/E/G ratio of 1.75 and a beta of 0.44.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share for the quarter, topping analysts’ consensus estimates of ($4.01) by $0.05. Humana had a return on equity of 11.43% and a net margin of 0.92%.The business had revenue of $32.64 billion for the quarter, compared to analyst estimates of $32.08 billion. During the same period in the prior year, the company earned ($2.16) EPS. The company’s quarterly revenue was up 11.3% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. On average, research analysts expect that Humana will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend is Friday, March 27th. Humana’s dividend payout ratio is currently 36.05%.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.